Last reviewed · How we verify

NCT05281432

Balance in Individuals With Pes Planus

Completed Last updated 16 March 2022
What this trial tests

trial in Pes Planus in 48 participants. Completed in 20 February 2022.

Timeline
12 April 2019
Primary endpoint
25 May 2021
20 February 2022

Quick facts

Lead sponsorIstanbul Medipol University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment48
Start date12 April 2019
Primary completion25 May 2021
Estimated completion20 February 2022
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 30 to 45, any sex, with Pes Planus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pes planus, one of the most common biomechanical disorders in the lower extremities, negatively affects the daily life of the individual and their competence in activities. The aim of this study was to evaluate the static and dynamic balance status of male individuals diagnosed with pes planus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pes Planus

Currently open trials in the same condition.

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05281432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing